bims-madeba Biomed News
on Mal de débarquement syndrome
Issue of 2019‒05‒26
one paper selected by
Jun Maruta
Mount Sinai Health System


  1. Future Sci OA. 2019 Apr;5(4): FSO377
    Mucci V, Canceri JM, Jacquemyn Y, Ombergen AV, Maes LK, Van de Heyning PH, Browne CJ.
      Aim: To evaluate if patients with Mal de Debarquement syndrome (MdDS) demonstrate different symptom levels or symptom type during pregnancy.Materials & methods: 18 MdDS patients that were or had been pregnant during their condition were recruited to complete a retrospective online questionnaire. Respondents answered questions regarding their basic clinical data, diagnosis, triggers and differences in symptom level and symptom type during pregnancy and before pregnancy.
    Results: A total of 81.3% reported that their symptoms were reduced during pregnancy compared with before pregnancy. Respondents also reported a different perception of motion and experienced less dizziness while being pregnant.
    Conclusion: The physiological changes that occur during pregnancy improve the symptoms of patients with MdDS, and this is potentially attributable to the rise in estrogen and progesterone.
    Keywords:  Mal de Debarquement syndrome (MdDS); MdDS symptoms; estrogen; pregnancy
    DOI:  https://doi.org/10.4155/fsoa-2018-0109